BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 14689352)

  • 1. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
    Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
    Sudre P; Rieder H; Bassetti S; Hirschel BJ; Ledergerber B; Malvy D
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2007-12. PubMed ID: 8984608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
    Gordin FM; Matts JP; Miller C; Brown LS; Hafner R; John SL; Klein M; Vaughn A; Besch CL; Perez G; Szabo S; El-Sadr W
    N Engl J Med; 1997 Jul; 337(5):315-20. PubMed ID: 9233868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
    Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
    Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(30):685-7. PubMed ID: 10947056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yield of tuberculin screening among injection drug users.
    Brassard P; Bruneau J; Schwartzman K; Sénécal M; Menzies D
    Int J Tuberc Lung Dis; 2004 Aug; 8(8):988-93. PubMed ID: 15305482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid TB prophylaxis effective in drug users with HIV.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison.
    Martín V; Caylà JA; Bolea A; Castilla J
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):41-6. PubMed ID: 10654643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
    Cohn DL
    Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
    Alaei K; Alaei A; Mansouri D
    East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent tuberculosis among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan: TSPOT.TB versus tuberculin skin test.
    Yen YF; Hu BS; Lin YS; Li LH; Su LW; Chuang P; Lin NC; Jiang XR; Shie YH; Chang HH; Ou WX; Zhan HJ; Yang W; Yen MY
    Scand J Infect Dis; 2013 Jul; 45(7):504-11. PubMed ID: 23768130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.